IL4 and head and neck squamous cell carcinoma: The results of the present study showed a significant tumor-associated increase of IL-4 when comparing patients with HNSCC and controls (P=0.0001), but unlike Mojtahedi et al (17), a significant decrease of IL-4 post-therapeutic (P=0.8500) was not found.